Treatment for Indigestion in Adults
For occasional indigestion in adults without contraindications, start with antacids for immediate relief, then progress to H2-receptor antagonists if needed, and finally to proton pump inhibitors (PPIs) for 4-8 weeks if symptoms persist. 1
Initial Management Approach
For new-onset dyspepsia (indigestion) in adults, the treatment strategy depends on age and symptom characteristics:
First-Line Treatment (Immediate Use)
- Antacids: Start here for symptomatic relief of occasional indigestion 1
- If antacids provide insufficient relief, progress to:
- H2-receptor antagonists (e.g., famotidine, ranitidine) 1, 2
- If H2-receptor antagonists fail after a reasonable trial, advance to:
- Proton pump inhibitors at standard dose for 4-8 weeks 3, 1
Age-Based Decision Making
For patients younger than 55-60 years without alarm symptoms:
- No endoscopy needed initially 3, 4
- Pursue empirical treatment as outlined above
- Test for Helicobacter pylori if symptoms persist or recur (using urea breath test or stool antigen test) 3, 1
- Eradicate H. pylori if positive before continuing other treatments
For patients 60 years or older:
- Endoscopy should be performed to rule out malignancy 4
Alarm Symptoms Requiring Immediate Referral
Do NOT treat empirically if any of these are present—refer for endoscopy immediately:
- Dysphagia (difficulty swallowing)
- Gastrointestinal bleeding or anemia
- Unintentional weight loss
- Recurrent vomiting
- Family history of gastric cancer 3, 2
Specific Medication Recommendations
PPIs (When Needed)
Any PPI can be used as absolute differences in efficacy are small 5:
- Omeprazole, lansoprazole, pantoprazole, esomeprazole, rabeprazole, or dexlansoprazole
- Dosing: Take 30-60 minutes before a meal for optimal effect 5
- Duration: 4-8 weeks for initial trial 3
- Standard once-daily dosing is appropriate; twice-daily dosing only if once-daily fails 6, 5
Important Caveats
Avoid chronic PPI use without clear indication:
- Chronic PPI use (seen in 7% of population) is associated with infections and osteoporosis 1
- Approximately 70% of patients on chronic PPIs can successfully discontinue them 1
- Long-term PPI use should be reserved for severe esophagitis, not routine dyspepsia 2
When symptoms persist despite treatment:
- Reassess for H. pylori if not previously tested 3
- Consider endoscopy if symptoms continue after empirical therapy in younger patients, though yield is low 3
- Reevaluate the diagnosis—consider functional dyspepsia, which may require different management including tricyclic antidepressants or prokinetic agents 4, 7
What NOT to Do
- Do not routinely use: Docusate (ineffective) 8, supplemental fiber like psyllium (may worsen symptoms) 8
- Do not perform routine endoscopy in young patients without alarm symptoms—it's not cost-effective 3
- Do not continue PPIs indefinitely without reassessing need 1, 2
This stepwise approach balances symptom relief with appropriate use of medications while avoiding unnecessary testing and long-term medication exposure.